91896 ⎘
Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
Sub-classes:Fluorinated phenylacetic acid derivatives in a weed control method
#2PROCESS FOR THE PREPARATION OF (9S)-2-BROMO-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPINE
#3Cannabinergic compounds and uses thereof
#4SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION
#5Substituted Aromatic Compounds and Pharmaceutical Uses Thereof
#6Hydrogen Bond Directed Photocatalytic Hydrodefluorination and Methods of Use Thereof
#7Substituted aromatic compounds and related method for the treatment of fibrosis
#8Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
#9Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
#10LUMINESCENT NANOCRYSTAL COMPLEX
#11Process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
#12Cannabinergic compounds and uses thereof
#13MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#14Resist composition and patterning process
#15Method for producing optically active 2-(2-fluorobiphenyl-4-yl) propanoic acid
#16Substituted aromatic compounds and related method for the treatment of fibrosis
#17Substituted aromatic compounds and pharmaceutical uses thereof
#18Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
#19MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#20Resist composition and patterning process
#21Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
#22HALOGENATED COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#232-ARYL-ZINC-PROPIONATE CATALYST AND PREPARATION METHOD AND USE THEREOF
#24Novel Cannabinergic Compounds and Uses Thereof
#25Substituted aromatic compounds and related method for the treatment of fibrosis
#26Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
#27Halogenated compounds for cancer imaging and treatment and methods for their use
#28Substituted aromatic compounds and pharmaceutical uses thereof
#29NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS
#30Process for preparing carboxylic acids
#31Haloalkylmethyleneoxyphenyl-substituted ketoenols
#32Multiple-component solid phases containing at least one active pharmaceutical ingredient
#33Haloalkylmethyleneoxyphenyl-substituted ketoenols
#34PREPARATION OF 2-(4-BROMOPHENYL)-2-METHYLPROPANOIC ACID
#35Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
#36Method for producing (2,4-dimethylbiphenyl-3-yl)acetic acids, the esters thereof and intermediate compounds
#37Substituted aromatic compounds and pharmaceutical uses thereof
#38Process for the preparation of cinacalcet and salts thereof, and intermediates for use in the process
#39METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES
#401-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
#412-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
#42PROCESS FOR THE MANUFACTURE OF RACEMIC 2-ARYL-PROPIONIC ACID
#43CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
#44SALTS OF MEMANTINE AND COX-INHIBITORS AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN
#45STEROSELECTIVE SYNTHESIS OF CERTAIN TRIFLUOROMETHYL-SUBSTITUTED ALCOHOLS
#46Haloalkylmethyleneoxyphenyl-substituted ketoenols
#472-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
#48Method for producing optically active ester and method for producing optically active carboxylic acid
#49Naphthylacetic acids
#50Arylphenyl-substituted cyclic keto-enols
#51SALT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND ORGANIC AMINE COMPOUND AND USE THEREOF
#52Benzothiazin-3-one compound and intermediate therefor
#53Iodine-phenyl-substituted cyclic cetoenols
#54GSM INTERMEDIATES
#55Carbon linked modulators of gamma-secretase
#56ORGANIC NITRIC OXIDE DONOR SALTS OF NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#57PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF HETEROCYCLIC SULFONAMIDE COMPOUNDS
#58Preparative-scale separation of enantiomers of chiral carboxylic acids
#59Specific caspase-10 inhibitors
#60Methods for administering FGF18
#61Arylphenyl-substituted cyclic keto-enols
#62Benzothiazin-3-one compound and intermediate therefor
#63Optical apparatus and methods for chemical analysis
#64Process for transition metal-catalyzed asymmetric hydrogenation of acrylic acid derivatives, and a novel catalyst system for asymmetric transition metal catalysis
#65Triaryl compounds and derivates thereof
#66Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
#67Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid
#68Process for preparing(+)-2-(4-chlorophenyl)-3-methyl butanoic acid
#69Process for producing optically active carboxylic acid substituted in 2-position
#70Process for the production of optically active compounds having substituents at the 2-position
#71Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
#722-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
#73Process for producing optically active flurbiprofen
#74Arylphenyl-substituted cyclic ketoenols
#75Geminally di-substituted NSAID derivatives as Aβ42 lowering agents
#76Supported catalyst containing active titanium in the homo, co-, and ter-polymerization of olefin-unsaturated compounds
#77Process for producing optically active 2-substituted carboxylic acid
#78Narcotic-NSAID ion pairs
#79Substituted phenylketoenols
#802-aryl-propionic acids and pharmaceutical compositions containing them